Dren Bio Announces $350 Million Financing for Drug Development
Dren Bio says the financing will advance dibotatug toward commercialization and accelerate development of its broader pipeline.
Related stories
Proya Shares Hit Limit Down, Fall 8.4% in Morning Trade
China cosmetics maker Proya traded at its daily limit-down level of 48.86 yuan, its lowest since Feb. 4, 2020, before closing the morning session down 8.4%. Citi cut its price targ
M impact | EQUITY | Oct 30, 2026, 04:46 AM UTC
Amazon Shares Fall 6% After Disappointing Wall Street
Amazon shares fell 6%, according to the headline.
M impact | EQUITY | Oct 30, 2026, 04:33 AM UTC
Asian session market picture: S&P 500 -0.91%, Nasdaq 100 -1.92%; USD/JPY -0.2%, WTI +1.15%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 0.91 percent, Nasdaq futures is down 1.92 percent, Dow futures is down 0.2 percent and Russell futures is do
M impact | EQUITY | Oct 30, 2026, 04:30 AM UTC
Indian shares inch higher as IT stocks and earnings rebound offset oil pressure
The Nifty 50 added 0.24% to 22,987.40 and the Sensex rose as IT stocks and post-results gains offset pressure from higher crude prices.
M impact | EQUITY | Oct 30, 2026, 04:29 AM UTC
Reliance Industries Q2 Profit May Top Rs 21,000 Crore
Reliance Industries is expected to report September-quarter profit above Rs 21,000 crore, with refining and Jio cited as earnings drivers. The company is scheduled to announce resu
M impact | EQUITY | Oct 30, 2026, 04:11 AM UTC
Australian Energy Stocks Reach One-Week High as Oil Rises
Australian energy stocks reached a one-week high as supply concerns lifted oil prices.
M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC